Economic Time 4 hours ago
Hyderabad-based Bharat Biotech is set to scale up production of its indigenously developed Covaxin to 12 million doses a month by July from the current 5 million, providing a critical boost to India’s Covid-19 inoculation programme amid a second wave of infections.
2倍產量 = 2倍股價
set限價14 SH到7月了